Gregg Sando (Cell Medica Ltd.)

Sando, Gregg (Cell Medica 2006–201807 CEO + Founder RESIGNED 8/18)

	Organisation	Cell Medica Ltd.
	Product	cell therapy
	Product 2	CAR T-cell technology (Chimeric Antigen Receptor T-Cell technology)

Record changed: 2019-03-02

Picture Berlin Partner Top News New Ariceum Radiopharma Lab 650x200px

More documents for Gregg Sando

[1] Cell Medica Ltd.. (2/15/18). "Press Release: Cell Medica Announces the Appointment of Kevin Boyle as Chief Financial Officer"....
[2] Cell Medica Ltd.. (8/1/18). "Press Release: Cell Medica Appoints New CEO to Drive CAR and TCR Clinical Development and Commercialisation". London & Houston, TX....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)